Table 3.
Treatment modalities and recurrence outcomes
| Variable | All Women N= 335 (%) |
African-American N= 100 (%) |
White-American N=235(%) |
P-Value |
|---|---|---|---|---|
| Surgery | .615 | |||
| Bilateral Simple Mastectomy | 5 (1.8) | 1 (1.0) | 4 (2.2) | |
| Unilateral Simple Mastectomy | 77 (23.5) | 26 (26.8) | 51 (22.1) | |
| Modified Radical Mastectomy | 36 (11.0) | 8 (8.2) | 28 (12.2) | |
| Breast Conserving Surgery | 208 (63.6) | 62 (63.9) | 146 (75.7) | |
| Missing | 9 | 3 | ||
| Radiation | .612 | |||
| Yes | 143 (45.1) | 44 (47.3) | 99 (44.2) | |
| No | 172 (54.9) | 49 (52.7) | 123 (55.8) | |
| Missing | 20 | 7 | 13 | |
| Final Treatment | .736 | |||
| Mastectomy | 118 (37.2) | 35 (37.2) | 83 (37.2) | |
| BCS with radiation | 135 (42.2) | 42 (44.7) | 93 (41.1) | |
| BCS without radiation | 66 (20.6) | 17 (18.1) | 48 (21.7) | |
| Missing | 17 | 6 | 11 | |
| Re-Excision | .342 | |||
| Yes | 7(10.5) | 1 (5.0) | 6 (12.8) | |
| No | 60 (89.5) | 19 (95.0) | 41 (87.2) | |
| Tamoxifen | .997 | |||
| Yes | 44 (14.0) | 13 (14.0) | 31 (14.0) | |
| No | 269 (86.0) | 80 (86.0) | 189 (86.0) | |
| Missing | 22 | 7 | 15 | |
| Follow-up Time in Years (mean± SD) | 8.10 (± 3.2) | 9.25 (± 4.0) | 9.00(± 4.4) | .710 |
| Second Breast Cancer | .003 | |||
| Yes | 34 (10.4) | 18 (17) | 16 (7.2) | |
| No | 301 (89.6) | 82 (83) | 219 (92.8) | |
| Diagnosis of Second Cancer | .154 | |||
| Invasive | 19 (55.9) | 8 (44.4) | 11(68.7) | |
| In Situ | 15 (44.1) | 10 (55.6) | 5(32.3) | |
| Site of Second Cancer | .388 | |||
| Ipsilateral | 19 (54.3) | 12 (66.7) | 7 (41.2) | |
| Contralateral | 13 (40.0) | 5 (27.8) | 8 (52.9) | |
| Both breasts | 2 (5.7) | 1 (5.6) | 1 (5.9) | |